Literature DB >> 24171272

Female reproduction physiology adversely manipulated by thyroid disorders: a review of literature.

Azad Reza Mansourian1.   

Abstract

Proper thyroid function is vital to have a healthy reproduction system. Female sex hormones are altered due to hypothyroidism and hyperthyroidism. Female reproduction system is negatively manipulated by both hyperthyroidism and hypothyroidism and menstrual disorders are the ultimate consequences. Hypomenorrhea, polymenorrhea and oligomenorrhea are the clinical manifestation associated with hyperthyroidism and hypothyroidism, respectively. The female infertility is also adversely affected by thyrotoxicosis and myxedema, the clinical presentation of hyper and hypothyroidism. The simultaneous existence of autoimmunity which is present among some portion of pregnant women may aggravate the clinical manifestation of thyroid disorders in female reproductive physiology. Abortion, premature infants, low birth infant, are among clinical presentation of overt hypothyroidism. Auto antibody against thyroid stimulating hormone receptor and eventual hyperthyroidism considered as risk factors which require extra attention while the thyroid disorder is clinically managed during pregnancy to prevent the fetus from abnormal metabolism. The aim of this review is to elaborate the adverse role of hyperthyroidism and hypothyroidism in female reproduction physiology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24171272     DOI: 10.3923/pjbs.2013.112.120

Source DB:  PubMed          Journal:  Pak J Biol Sci        ISSN: 1028-8880


  2 in total

1.  Prevalence of thyroid dysfunction among young females in a South Indian population.

Authors:  Kumaravel Velayutham; S Sivan Arul Selvan; A G Unnikrishnan
Journal:  Indian J Endocrinol Metab       Date:  2015 Nov-Dec

2.  Detection of mutations in the CYP21A2 gene: genotype-phenotype correlation in Slovenian couples with conceiving problems.

Authors:  Š Stangler Herodež; L Fijavž; B Zagradišnik; N Kokalj Vokač
Journal:  Balkan J Med Genet       Date:  2016-07-09       Impact factor: 0.519

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.